Viswatej Avutu

Viswatej Avutu serves as an Assistant Professor in the Department of Medicine at Memorial Sloan Kettering Cancer Center, specializing in sarcoma oncology within the Solid Tumor Oncology Division and Sarcoma Service. Active in the Hematology-Oncology Fellows program, his clinical focus spans pediatric and adult sarcoma subtypes including osteosarcoma, leiomyosarcoma, and soft tissue sarcomas.

His research centers on immunotherapy combinations, molecular biomarker discovery, and histology-specific clinical trials. Key areas include CSF1R/PD-L1 inhibitor combinations, PARP inhibitors with immunotherapy, and WEE1 kinase targeting. Avutu frequently investigates circulating tumor DNA as a biomarker and explores immune-related adverse events as predictors of treatment response.

Publications reveal a strong emphasis on

• Phase I/II trials for novel sarcoma agents
• Subtype-specific treatment paradigms (e.g., myxofibrosarcoma vs. undifferentiated pleomorphic sarcoma)
• Translational applications of biomarkers in gastrointestinal stromal tumors

His collaborative network includes prominent researchers like Mrinal Gounder, Mark Dickson, and Ciara Kelly across 35+ publications since 2022.

Avutu actively contributes to clinical trial design through the Children's Oncology Group and focuses on harmonizing treatment approaches for adolescent/young adult osteosarcoma patients. His work bridges laboratory insights with clinical applications in sarcoma therapeutics.